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The Autographa californica nuclear polyhedrosis virus da26 gene codes for an envelope protein of both budded virus (BV)
and occlusion derived virus (ODV). Western blot and temporal analysis of infected cell extracts detected a protein of 26 kDa
by 4 h postinfection (p.i.). The amount of protein increased by 16 h p.i. and remained at high levels throughout infection. By
36 h p.i. several additional immunoreactive proteins were detected which migrated at '18 kDa and remained through 96 h
p.i. Western blot analysis of purified virus envelope and nucleocapsid preparations revealed that both the 26- and 18-kDa
proteins are structural proteins of the envelope of BV and ODV. Immunoelectron microscopy performed at a time when only
the 26-kDa species of the protein was present confirmed that the protein located to ODV envelope. The protein was named
BV/ODV-E26 to designate incorporation into viral progeny, envelope location, and apparent molecular weight. Studies
designed to follow localization of BV/ODV-E26 demonstrated that early in infection, the protein was incorporated into
cytoplasmic vesicles and by 16 h p.i., BV/ODV-E26 was detected in the nucleus associated with virus-induced intranuclear
microvesicles and ODV envelope. Coimmunoprecipitation and yeast two-hybrid assays showed that BV/ODV-E26 and FP25K
were capable of interacting with each other to form a complex and coimmunoprecipitation assays indicated that cellular actin
was a third component of this complex. Together, these data suggest that FP25K and cellular actin may participate in the
regulation, or movement through the cell, of baculovirus proteins and/or virus nucleocapsids. © 1998 Academic Press
INTRODUCTION
Baculoviruses infect larvae of susceptible insects
and produce two functionally distinct virus progeny
during the infection cycle: budded virus (BV) and oc-
clusion-derived virus (ODV). BV acquires a viral enve-
lope early in the infection process by budding through
the plasma membrane, whereas ODV matures later in
infection by obtaining a viral envelope from an intranu-
clear source of membrane microvesicles. The protein
composition of BV and ODV envelopes are different
(Smith and Summers, 1978, 1981; Braunagel and Sum-
mers, 1994), and while several ODV envelope-specific
proteins are now identified, gp64 is the only protein
known to be specific to the BV envelope (Volkman and
Goldsmith, 1985; Whitford et al., 1989). The maturation
of BV and ODV is temporally regulated. Optimal BV
maturation occurs prior to 24 h postinfection (p.i.) and
then decreases. Concomitant with the decrease of BV
maturation, ODV maturation in the nucleus is in-
creased and continues throughout infection. The fac-
tors that regulate the maturation of BV versus that of
ODV are currently unknown.
Expression of the da26 gene has been shown to stim-
ulate late gene transcription in cooperation with da41
(Guarino and Summers, 1988). Fusion constructs with
b-galactosidase did not adversely affect in vitro or per os
infectivity indicating that this protein is not essential for
infectivity (O’Reilly et al., 1990). When the da26 locus was
disrupted, a few polyhedra phenotype were produced
(O’Reilly et al., 1990). Unlike most genes which are ex-
pressed early and late in infection, da26 transcription
does not initiate from the well-defined baculovirus early
and late promoters, but rather from a cryptic sequence
(Guarino and Summers, 1988). Da26 RNA transcripts are
detected as early as 3 h p.i. and accumulate during
infection (O’Reilly et al., 1990).
In this study, we demonstrate that the product of the
da26 gene is the viral envelope protein, BV/ODV-E26
(ORF16; Ayres et al., 1994). Early in infection BV/ODV-E26
(-E26) locates to cytoplasmic vesicles, and later in infec-
tion -E26 is incorporated into membranes within the
nucleus. The fact that -E26 is a structural protein of BV
suggests that early in infection the protein is incorpo-
rated into the plasma membrane of the host cell. The
identification of a protein that exhibits temporally regu-
lated transport to the cell surface, and into membranes
within the nucleus, provides a unique tool to study intra-
cellular transport and regulatory factors required for the
maturation of BV and ODV. This study also shows that the
viral protein FP25K and cellular actin may form a com-
plex with -E26 and potentially participate in the transport
or regulation of transport of -E26.
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MATERIALS AND METHODS
Recombinant virus, protein expression, and antibody
production. The EcoRI A fragment of AcMNPV (E2 strain)
containing da26 was digested with EcoRII, filled with
Klenow, and subsequently digested with BamHI and
cloned into the SmaI, BglI sites of pUC 18 (pUC-da26).
This fragment ('800 nt) contained 21 nucleotides of
upstream nontranslated leader, the da26 gene, and da26
polyadenylation sites. The insert containing the da26
gene was then excised using EcoRI and PstI (provided
by the pUC vector) and further subcloned into pVL1393
(Webb and Summers, 1990) and pBS(2). Final constructs
were confirmed by DNA sequencing.
Recombinant virus was generated using pVL1393-
da26 and Bsu361-digested BacPak6 viral DNA (CLON-
TECH, Palo Alto, CA; Summers and Smith, 1987). Recom-
binant virus lacked the polyhedrin protein (occ-) and
showed a marked increase production of a 26-kDa pro-
tein. This recombinant virus was used for abundant ex-
pression studies and as the source of protein used as
injection antigen for production of antisera. Polyhedrin-
expressed 26-kDa protein was cut from SDS–PAGE gels,
eluted, and used as antigen for preparation of antibody.
Rabbits were injected every 28 days, for a total of four
injections with antigen (RIBI; Hamilton, MA). To generate
high affinity antisera, the second and third injections
contained approximately one-half the amount of the first
injection, and the final injection contained approximately
one-fourth the initial amount of antigen. Ten days after
the last injection, sera were collected and titer was
evaluated.
SDS–PAGE and Western blot analysis. Spodoptera fru-
giperda cells (Sf9) were infected with the E2 strain of
AcMNPV at a multiplicity of infection (m.o.i.) of 20, virus
was absorbed for 1 hr (time 0 is the time of addition of
virus) and then unabsorbed virus and media were re-
moved and replaced with TMNFH, 10% FBS. Cells were
collected at designated times post infection, pelleted,
and the protein concentration of the cell pellet was de-
termined by the method of Bradford (1976). Purified BV,
ODV, envelope and nucleocapsid fractions were pre-
pared as described in Braunagel and Summers (1994).
Vertical slab SDS–PAGE was performed according to
Laemmli (1970). A 4% stacking gel was used above a
12.5% separating gel. Before loading, samples were in-
cubated in 1.5% SDS, 0.5% b-mercaptoethanol, 25 mM
Tris–HCl (pH 6.8) and 7% glycerol for 15 min at 65°C.
Western blot analysis was performed using protein
blotted onto PVDF membrane (Immobilon-P; Millipore,
Bedford, MA). The membranes were blocked with TTBS–
BLOTTO (150 mM NaCl, 10 mM Tris, 1% nonfat dry milk,
0.002% sodium azide, 0.1% Tween 20, pH 8.0). Antibody
was bound overnight (4°C; No. 7554, 1:1000), blots were
washed twice with TTBS–BLOTTO, and horseradish per-
oxidase-linked anti-rabbit IgG (1:10,000) was bound for
1 h at room temperature. Blots were washed three times
with TTBS, reacted for 1 min with Renaissance (NEN,
Boston, MA) chemiluminescence reagent and exposed
to X-ray film.
Testing for immunorelatedness of the different molec-
ular weight protein species was performed by using
large scale SDS–PAGE which clearly separated the three
molecular weight species close to 26 kDa. Western blot
was performed on these gels and the location of each of
the proteins was identified by immunostaining a small
strip of the membrane. The remaining unstained bands
were bound to polyclonal sera to immunoselect antibod-
ies that were specific for each molecular weight protein
species and the blots were washed to remove unbound
antibody. A SDS–PAGE gel (15 mg of 48 h p.i. infected cell
lysate) and Western blot was completed and each lane
was incubated overnight (4°C) with the strip containing
the immunoselected antibody to one of the protein spe-
cies around 26 kDa. In this manner, the immunoselected
antibody was exchanged from one blot to the other
without exposing the antibody to denaturing conditions.
Antibody binding against the blot containing the 48-h p.i.
sample was detected using the chemiluminescence
techniques described above.
Immunoelectron microscopy (IEM). At the designated
time postinfection, the cell samples (m.o.i. 5 20) were
pelleted, fixed, and suspended in LR White (Hong et al.,
1994). Ultrathin sections were prepared, blocked with
TBS–BSA (150 mM NaCl, 10 mM Tris, 0.1% Tween 20, 1%
BSA, pH 8.0) for 15 min, reacted with primary antibody
(1:1000, 12 h, 4°C) and washed with TBS (4 3 2 min). The
bound primary antibody was detected using gold-conju-
gated anti-rabbit IgG (30 nM, Amersham, Arlington
Heights, IL). The sections were stained with uranyl ace-
tate (Bozzola and Russell, 1992) and lead citrate (Venable
and Coggeshall, 1965). Cells were observed using a
Zeiss 10C transmission electron microscope (Texas
A&M University Electron Microscopy Center).
Immunofluorescence microscopy. Cells were pro-
cessed for light microscopy using a modification of pre-
viously described procedures (Charlton and Volkman,
1991). A suspension of 5 3 105 Sf9 cells was applied to
a coverslip, allowed to adhere for 1 h, and infected at a
m.o.i. of 20 (27°C). At the appropriate time, cells were
rinsed with Grace’s media and fixed with 3.7% parafor-
maldehyde in PBS (pH 7.2, 20 mM phosphate, 140 mM
NaCl) for 10 min at room temperature. Subsequent steps
were performed at room temperature. Fixative was re-
moved and coverslips were rinsed twice with PBS–
BLOTTO (PBS containing 1% nonfat milk). Cells were
permeabilized by treatment with methanol (10 min) with
subsequent treatment of 0.5% Triton X-100 (10 min), fol-
lowed by two rinses with PBS. Nonspecific reactivity was
blocked by treatment with normal goat serum (1:20 in
PBS, 30 min), and cells were incubated in primary anti-
body (No. 7554; 1:1000 in PBS–BLOTTO) for 30 min. Cells
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were rinsed twice with PBS–BLOTTO and secondary
antibody [fluorescein isothiocyanate-conjugated anti-
rabbit IgG (FITC); Sigma, 1:100 in PBS–BLOTTO] was
added and incubated for 30 min. Cells were washed two
times with PBS–BLOTTO and nucleus was visualized by
staining the cells with DAPI (0.1 mg/ml in PBS) for 5 sec
and rinsing three times with PBS. Cells were mounted for
viewing using nonbleach mountant (10 mg phenylenedi-
amine/ml in 90% glycerol). Cells were viewed and pho-
tographed with a Zeiss Axiovert 135 Photomicroscope.
Membrane fractionation and triton X-114 assay. Cellu-
lar membranes were prepared as described by Wang
and Haunerland (1994). Briefly, this technique includes
lysing the cells (20 mM Tris, 140 mM NaCl, 1 mM CaCl2,
0.1 mM phenylmethylsulfonyl fluoride, 1 mM b-mercap-
toethanol, pH 8.0) separating the cell debris (10 min at
800 g) and sedimenting the membranes by 1-h centrifu-
gation at 30,000 g. The pellet was then washed with the
above buffer, and solubilized with 2% (v/v) Triton X-100 in
the same buffer (16 h, 4°C). The insoluble material was
separated from the membrane pellet by centrifugation
(100,000 g, 1 h). A 100-mg fraction of the membrane pellet
(see above; from 24 h p.i. Sf9 cells) was solubilized in 200
mL of Triton X-114 TN buffer (1% Triton X-114, 10 mM Tris,
0.15 M NaCl, pH 7.4) on ice for 20 min with occasional
agitation. The solubilized pellet was centrifuged at 13,000
g for 20 min at 4°C and the soluble supernatant fraction
overlaid onto a 300 mL sucrose cushion (6% sucrose, 10
mM Tris, 0.15 M NaCl, 0.06% Triton X-114, pH 7.4) at room
temperature and incubated at 37°C for 3 min. The sam-
ple was centrifuged for 3 min at 300 g to separate the
phases. The top aqueous phase was removed without
disturbing the sucrose cushion, mixed with Triton X-114
(1%), incubated on ice for 10 min, and overlaid onto the
original sucrose cushion. Phase separation was re-
peated as above. The final aqueous phase was removed
and extracted again by adding Triton X-114 (2%). The
phases were separated as described above and the
aqueous phase was collected. The detergent droplet at
the bottom of the sucrose cushion was recovered as the
final detergent phase. Both aqueous and detergent
phases were acetone precipitated and analyzed using
SDS–PAGE and Western blotting techniques.
Immunoprecipitation. Sf9 cells were labeled between
18 and 24 h p.i. with [35S]translabel (ICN) using 100 mCi
per 3 3 106 cells in 1 ml of methionine-free Grace’s
media. Cells were harvested at 24 h p.i. and lysed on ice
for 30 min in RIPT buffer (3 3 106 cells/ml RIPT; 50 mM
Tris, 100 mM NaCl, 0.2% Tween-20, and 10 mg/ml apro-
tinin, pH 8.0). Cells were disrupted by passage through a
25-gauge needle and debris and unbroken cells were
removed by centrifugation (13,000 g for 10 min, 4°C). Cell
extracts were mixed with antiserum (1:1000) and incu-
bated overnight at 4°C with gentle agitation. Protein-A
agarose beads (Sigma, 20 mL of 50% slurry) were added,
incubated for 1 h at 4°C and immunoprecipitates were
collected by centrifugation (1000 g for 3 min, 4°C). Beads
were washed two times with RIPT buffer and once with
TBS. A sample of the beads were incubated at 65°C for
15 min in 20 ml of SDS–PAGE sample buffer and the
equivalent of 3 3 106 cells/lane were analyzed by West-
ern blotting. 35S-labeled proteins were visualized by au-
toradiography.
Yeast two-hybrid assay. Using oligonucleotides and
PCR, an EcoRI site was incorporated immediately up-
stream of the da26 gene and a BamHI site was incorpo-
rated immediately after the stop codon. These restriction
sites were used to clone da26 into the yeast vectors
pACT2 and pAS2-1 in frame with gal4. Restriction sites
were also incorporated upstream and downstream of the
FP25K gene using oligonucleotides and PCR. Immedi-
ately upstream of the FP25K initiation codon, both EcoRI
and NcoI restriction sites were added, while a BamHI
site was incorporated immediately downstream of the
stop codon. The gene was cloned into pUC 18 using the
EcoRI and BamHI restriction sites. The FP25K clone was
then transferred to the yeast plasmid, pAS2-1 using the
NcoI and BamHI restriction sites (pAS2-1/FP25K). Using
the pAS2-1/FP25K plasmid as source, the FP25K gene
was transferred to the yeast plasmid pACT2 using NdeI
(provided by pAS2-1) and BamHI sites. Yeast expression
constructs were confirmed by DNA sequencing. Trans-
fection and chromogenic reactions were performed ac-
cording to manufacturer’s protocol (CLONTECH, Palo
Alto, CA).
RESULTS
BV/ODV-E26 (-E26) is a structural protein of BV and
ODV. To determine the time course expression of the
da26 gene product, cell extracts were collected at vari-
ous times postinfection and analyzed by Western blotting
techniques using polyclonal antibodies generated to
-E26. The blot was overexposed in order to visualize the
low amounts of protein associated with the cell lysate
early in infection. Through 24 h p.i. one predominant
immunoreactive band was detected at 26 kDa. This pro-
tein was detected as early as 4 h p.i. (Fig. 1, lane 5),
accumulated to higher levels by 16 h p.i. and remained at
high levels throughout infection (Fig. 1, lanes 5–13). It
should also be noted that these experiments were per-
formed using cell lysates, thus protein that was pro-
duced, incorporated into budded virus and released into
the media, would not be detected. By 36 h p.i. several
lower and higher molecular weight immunoreactive pro-
teins were also detected (Fig. 1, lanes 10–13). To deter-
mine if the broad banding pattern of both the 26- and
18-kDa proteins represented multiple proteins, the blot
was exposed for less time. The decreased exposure
showed that in both molecular weight regions (26 and 18
kDa), the broad diffuse banding pattern was the result of
multiple protein species (Fig. 1, lane 14, arrows). In vitro
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translation results predicted one major protein product of
26 kDa; however, minor lower molecular weight products
were also detected (Fig. 1, lane 21).
The banding pattern of the immunoreactive proteins
species at time points later than 24 h p.i. was complex.
To address the nature of this banding pattern, a large
format SDS–PAGE, Western blot experiment was per-
formed which clearly separated the three protein bands
clustered at 26 kDa. Each of the protein species was cut
from the blot and used to immunoselect antibodies spe-
cific for that protein species (1 to 3 represents highest to
lowest molecular weight, respectively). A second SDS–
PAGE and Western blot was then prepared using 48-h p.i.
infected cell extract samples (15 mg) and reacted with
each immunoselected antibody. As shown in Fig. 1B
(lanes 1–3), each immunoselected antibody not only rec-
ognized the 26-kDa protein species but also the addi-
tional species around 34 and 18 kDa. The 26- and 18-kDa
protein species were each highly reactive with all of the
immunoselected antibodies (Fig. 1B, lanes 1–3), while
the 34 kDa was highly reactive to the middle band (Fig.
1B, lane 2), but less so with the highest and lowest
protein species-selected antibodies (Fig. 1B, lanes 1 and
3). These data indicate that the complex protein-banding
pattern either represents the same protein that is oli-
gomerized, or processed, or represents different proteins
that are so immunologically related that the antibody
cannot distinguish between them.
BV, ODV, viral envelope, and nucleocapsid fractions
were analyzed to determine if the immunoreactive pro-
teins were components of the mature virus. The purity of
the virus envelope and nucleocapsid preparations were
tested using antibodies to other known ODV and BV
structural proteins. The banding patterns of p39, ODV-
E56, gp67, ODV-E18 ODV-EC27 were consistent with pre-
vious results (data not shown). In total BV, the major
immunoreactive protein was 26 kDa; however, the puri-
fied envelope contained both 26- and 18-kDa proteins,
although the 26 kDa was the major reactive band (Fig. 1;
lanes 15 and 16). Total ODV contained both 18- and
26-kDa proteins, and these were also present in the
purified envelope (Fig. 1, lanes 18 and 19). Unlike BV, ODV
contained much more of the 18-kDa protein species, in
both total virus and purified envelope. Both BV and ODV
FIG. 1. (A) Temporal time course and protein localization. Infected cell extracts and Western blots prepared and reacted against primary antibody
(a-E26, #7554; 1:1000), horseradish peroxidase secondary antibody, and reaction product visualized using chemiluminescence techniques. The
temporal time of appearance of BV/ODV-E26 was determined (lanes 4–13; M, uninfected Sf9 cells; time 5 h postinfection). Purified virus (lanes 15
and 18), viral envelope (lanes 16 and 19), and nucleocapsid (lanes 17 and 20) fractions were prepared and tested to determine the viral location of
BV/ODV-E26. Crossreactivity of cellular and viral proteins to preimmune sera was tested (lanes 1–3). In vitro translation reveal the molecular weight
of the major gene product (lane 21). (B) Immunorelatedness of proteins. Western blot of 48-h p.i. cell lysate (15 mg lane) reacted against
immunoselected antibodies to the three protein species contained within the 26-kDa protein band. Lane 1 represents cell lysate reaction to the largest
protein band, lane 2 is reacted to the middle protein band, and lane 3 is reacted against antibodies selected to the smallest band (see Fig.
1A, lane 14).
67AcMNPV ENVELOPE PROTEIN, BV/ODV-E26
nucleocapsid fractions contained detectable 26- and/or
18-kDa proteins, which is consistent with the normal
amount of envelope contamination of the nucleocapsid
preparation (,10%; Fig. 1, lanes 17 and 20; Braunagel
and Summers, 1994). Preimmune serum demonstrated
little cross reactivity with both cellular and viral proteins
(Fig. 1, lanes 1–3).
The protein was named BV/ODV-E26 to identify it as a
structural protein of BV and ODV, was localized in the
envelope, and has an apparent molecular weight of 26
kDa for the predominant form.
Because of the multiple forms of immunoreactive pro-
teins that are detected after 24 h p.i in infected cell
lysates, studies designed to identify the fine structure
FIG. 2. Immunogold localization of BV/ODV-E26 at 6 h p.i. (A) Preimmune antisera. (B–H) Immunoreaction using antibody to BV/ODV-E26, and 30
nM conjugated gold secondary antibody. n, nucleus; c, cytoplasm. Closed arrow, labeled cytoplasmic vesicles; open arrow, intranuclear electron
dense regions; arrowheads, labeled cytoplasmic electron dense structures. Size bar represents 10 mm.
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localization of -E26 were performed at early time points
when the 26-kDa protein was the predominant form (i.e.,
up to and including 24 h p.i.). IEM studies revealed that
at 6 h p.i., -E26 was observed in cytoplasmic vesicles
(Figs. 2C–2H, solid arrows). Most observations detected
-E26 in membrane structures of small, discrete vesicles;
however, it was also detected in more complex vesicles
(Fig. 2D, arrows). Even in these more complex structures
however, -E26 appeared to be membrane associated. A
more rare observation was the detection of BV/ODV-E26
within cytoplasmic electron dense structures (Fig. 2B;
arrowhead). Early in infection a consistent feature of -E26
localization was the detection of the protein within the
nucleus and in association with electron dense regions
(Fig. 2C; open arrows). Labeled cytoplasmic vesicles and
intranuclear electron dense regions were not observed
by 16 h p.i. (data not shown).
By 24 h p.i. -E26 was concentrated within virus-in-
duced intranuclear microvesicles (Fig. 3B, open arrows),
and ODV envelopes (Figs. 3C and 3D, arrows). BV/ODV-
E26 was also detected in BV envelope and the plasma
membrane (data not shown). The use of preimmune
serum shows that background labeling in both cellular
and viral structures is minimal (Figs. 2A and 3A).
Temporal analysis of transport of BV/ODV-E26 to the
nucleus. At 6 h p.i., light microscopy, immunofluores-
cence label was concentrated predominately in punctate
structures within the cytoplasm (Fig. 4A, 4a, arrow). The
intracellular punctate structures correlate with the local-
ization of -E26 in cytoplasmic membrane-bound vesicles
as visualized by IEM (Fig. 2).
At 16 h p.i., -E26 was located in discrete foci within the
nucleus (Fig. 4B, 4b, solid arrow). Also at 16 h p.i., a
significant amount of -E26 was also detected in the
cytoplasm (Fig. 4B, 4b; dashed arrow).
By 24 h p.i. -E26 was predominantly detected within
the nucleus in discrete foci (Fig. 4C, 4c, arrow). This
localization was consistent with IEM observations
which show that -E26 located to intranuclear mi-
crovesicles (Fig. 3). Control experiments, including
binding of preimmune serum against infected cells at
all time points, and serum tested against uninfected
Sf9 cells did not show detectable binding (data not
shown).
FIG. 3. Immunogold localization of BV/ODV-E26 at 24 h p.i. (A) Preimmune antisera. (C–D) Labeling of microvesicles (open arrow) and ODV envelope
(closed arrow). n, nucleus; c, cytoplasm; m, microvesicles; v, virogenic stroma. Size bar represents 10 mm.
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BV/ODV-E26 is likely a peripheral membrane protein.
Computer-assisted structural analysis of -E26 does not
predict the existence of a membrane spanning domain in
this protein (GenBank Accession No. L22858, nucleo-
tides 13092–13767); however, -E26 clearly associates
with membranes in the cytoplasm and nucleus. To test if
-E26 is an integral or peripheral membrane protein, Tri-
ton X-114 detergent phase partition assay was per-
formed. When infected cells (24 h p.i.) were separated
into soluble and membrane fractions, the majority of -E26
partitioned with the membrane fraction and the three
closely migrating protein bands of -E26 ('26 kDa) were
easily visualized (Fig. 5A, lanes 1–2). When the mem-
brane fraction (Fig. 5A, lane 2) was further analyzed and
treated with Triton X-114, -E26 partitioned into the aque-
ous phase (Fig. 5B, lane 1). These data suggest that -E26
is a peripheral membrane protein.
BV/ODV-E26, FP25K, and actin may form a protein
complex. To identify cellular or viral proteins potentially
interacting with -E26, [35S]Met-labeled infected cell lysates
(24 h p.i.) were immunoprecipitated with antibody to -E26
and immunoprecipitates analyzed by SDS–PAGE and West-
ern blotting techniques. Approximately eight proteins were
immunoprecipitated (Fig. 7A, lane 1) with -E26 being an
abundant protein (Fig. 7A, lane 2). Previous work in this
laboratory suggests that FP25K may effect the transport of
some baculovirus ODV envelope-specific proteins (unpub-
lished observations); therefore, we tested for the presence
of FP25K in the immunoprecipitated sample. FP25K was
detected among the proteins precipitated by the -E26 anti-
body (Fig. 7A, lane 3). Immunoprecipitation experiments
performed with control preimmune antisera did not reveal
either FP25K or actin in the immunoprecipitated pellet (data
not shown). To test for direct interaction between FP25K
and -E26 a yeast two-hybrid assay was performed (FP25K,
activation domain; -E26, binding domain) and a positive
interaction between these proteins was demonstrated (Fig.
7B, iii.). Transfection of either plasmid alone did not result in
color reaction product (data not shown) and control plas-
mids produced the predicted chromagenic reaction (Fig.
7B, i, ii).
Both FP25K and -E26 contain regions of similarity to
the actin-binding proteins myosin and tropomyosin
(BLAST/BEAUTY, Altschul et al., 1990) and examples of
these homologies are shown in Fig. 6. In addition to the
example shown for -E26 to tropomyosin, -E26 also had
regions of homology to myosin (data not shown). FP25K
contains regions of homology to myosin (Fig. 6B) and
cytoplasmic dyneins (data not shown). In addition, FP25K
contains a region that resembles the actin-binding helix
present in gelsolins and profilins (Fig. 6C; McLaughlin et
al., 1993). Because of the presence of these homologies
in both -E26 and FP25K, we tested for the presence of
actin in the -E26-immunoprecipitated preparation. A pos-
itive immunoreaction with monoclonal antibody to actin
was obtained (Fig. 7A, lane 4; C4; Boehringer-Mann-
heim), indicating that actin could be part of a protein
complex that includes -E26 and FP25K.
FIG. 5. Membrane association of BV/ODV-E26. (A) Western blot
showing cofractionation of BV/ODV-E26 with the cellular membrane
fraction. Lane 1, soluble fraction from 24 h p.i. Sf9; lane 2, membrane
fraction. (B) Triton X-114 detergent phase partition assay. Lane 1, aque-
ous phase of Triton X-114-treated membrane fraction; lane 2, detergent
phase.
FIG. 4. Light microscopy localization of BV/ODV-E26. Sf9 cells were
infected and primary antibody to BV/ODV-E26 (No. 7554, 1:1000) was
used along with FITC-labeled secondary antibody. DAPI staining was
performed to visualize the nucleus. Data are presented either as FITC
exposure alone (a,b,c) or FITC/DAPI dual exposure (A,B,C). (A, a) 6 h p.i.
(B, b) 16 h p.i. (C, c) 24 h p.i.
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The timing and amount of BV/ODV-E26 may be impor-
tant for correct -E26 protein localization. Expression of
genes cloned under the transcriptional regulation of the
polyhedrin gene promoter (baculovirus expression vec-
tor system, BEVS) allows abundant expression of -E26
and expression in a different temporal pattern. The use
of BEVS-expressed ODV-E66 showed that such an ap-
proach could be useful to detect potential sites of protein
localization in the transport pathway (Hong et al., 1997).
Cells infected with a recombinant baculovirus express-
ing -E26 under the control of the polyhedrin promoter
resulted in an unusual morphology of the virogenic
stroma. At 24 h p.i. small regions within the virogenic
stroma appeared more electron dense than normal (Fig.
8A; compare regions at small arrow vs large arrow);
however, the appearance of enveloped virus was normal
(Fig. 8A, open arrows). By 48 h p.i. varying degrees of
unusual virogenic stroma morphology were detected. For
example, Fig. 8B (large arrow) shows increased concen-
trations of the electron-dense material within the viro-
genic stroma, while in many cells the virogenic stroma
was largely dispersed and exhibited a granular appear-
ance (Figs. 8C and 8D, large arrows). In these cells -E26
was abundantly present in the virogenic stroma that
exhibited the condensed granular appearance (Figs. 8C,
and 8D, and 8H). Localization of -E26 in other cellular
and viral structures was normal: It still located to intranu-
clear microvesicles; ODV envelope (Fig. 8E, m and open
arrows); nuclear envelope; and plasma membrane (Fig.
8G, arrowheads). By 72 h p.i., the virogenic stroma was
highly condensed (Fig. 8F, arrow).
DISCUSSION
The da26 ORF predicts a protein size of 26 kDa but the
migration pattern on SDS–PAGE gels was more complex.
SDS gels show that BV/ODV-E26 migrates as a single
band of 26 kDa in cell extracts early in infection, but later
in infection closely migrating bands at 25 kDa are de-
tected; as well as several bands at 18 kDa and an
additional band at 34 kDa (Fig. 1). While we don’t under-
stand the nature of the multiple immunoreactive species
of proteins, immunoselection experiments indicate that
these proteins species are highly immunorelated. It is
possible that the differences in molecular weights are
due to posttranslational modifications, protein process-
ing, or protein degradation. However, -E26 is not glyco-
sylated or phosphorylated, and the multiple protein forms
are visible when protease inhibitors are used during
sample preparation (data not shown). The proteins of
closely related molecular weights of 26 and 18 kDa are
present in purified virus; however, we note that the 26
kDa form is the predominant species present in BV.
These data suggest that these multiple forms of -E26
FIG. 6. Amino acid relationship between BV/ODV-E26, FP25K, and actin-binding proteins. (A) BV/ODVB-E26 homology with human tropomyosin (No.
P06468). (B) FP25K homology with Saccharomyces cerevisiae myosin (No. X53947). (C) Potential actin-binding region of FP25K (gs1, vs1, ss1, human
gelsolins; paca 1, paca 2-Acanthamoeba castellani profilins; pryst, Saccharamyces cerevisiae profilin).
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may have structural or functional significance during viral
infection or assembly.
We do not understand the nature or significance of the
condensation of the virogenic stroma that results from
abundant expression of BV/ODV-E26. Consistent with
other observations of structural proteins expressed at
levels higher than normal (unpublished observations),
this result indicates that it is important for AcMNPV
structural proteins to be present in cells in the proper
stoichiometric amounts or have the proper temporal ex-
pression for normal interactions. Since -E26 has been
shown to be required for late gene expression (in con-
junction with da41; Guarino and Summers, 1988), we
speculate that there is an association of -E26 with viral
DNA or DNA-binding proteins. Such an interaction could
account for the localization of -E26 in electron-dense
regions within the nucleus early in infection (Fig. 2) and
the structurally altered virogenic stroma upon abundant
-E26 expression (Fig. 8).
Compared to previously described proteins that only
locate to the BV or ODV envelope, -E26 is unique. Its
incorporation into the envelope of BV would imply that
the protein is transported to the cell plasma membrane
early in infection (6 h p.i.) and immunogold experiments
suggest that transport may be mediated through cyto-
plasmic membrane vesicles (Figs. 2 and 4). While it is
possible that the labeled cytoplasmic vesicles could be
the result of inoculum virus, time course immunofluores-
cence studies do not support this conclusion: The punc-
tate pattern of label only occurs between 4 and 8 p.i., a
time that is consistent with a BV envelope protein being
transported to the cell surface. If these punctate patterns
were the result of inoculum virus, one would predict that
they would be present at very early time points, a result
that is not visualized (data not shown). At later time
points, -E26 is directed into the nucleus where it asso-
ciates with intranuclear microvesicles and ODV envelope
(Fig. 3). The pathway and regulation of nuclear transport
of -E26 is unknown. All ODV envelope proteins charac-
terized thus far contain at least one potential hydropho-
bic membrane-spanning domain (Hong et al., 1997); how-
ever, such a domain cannot be predicted from the
primary amino acid sequence of -E26. BV/ODV-E26, how-
ever, does contain a sequence of basic amino acids that
resembles a classical or bipartite nuclear localization
sequence (HKKKLR X6 RKK; Dingwall and Laskey, 1991).
The presence of a nuclear localization sequence and the
apparent peripheral nature of membrane association of
-E26 (Fig. 5) allows speculation that -E26 may be trans-
ported into the nucleus through the nuclear pores. Trans-
port utilizing this pathway would suggest that once in-
side the nucleus, -E26 disassociates with transport
FIG. 7. BV/ODV-E26 interaction with other proteins. (A) Immunoprecipitation of 24 h p.i. Sf9 cell extracts with antibody BV/ODV-E26 antibody. Lane
1, 35S-labeled immunoprecipitated proteins. Lane 2, immunoprecipitated sample probed with antibody to BV/ODV-E26. Lane 3, immunoprecipitated
sample probed with antibody to FP25K. Lane 4, Immunoprecipitated sample probed with antibody to actin (C4). (B) Yeast two-hybrid assay. i, negative
control; ii, positive control, iii, cotransfection of the FP25K (AD)-gal4 activation domain fusion construct and the BV/ODV-E26 (DB)-gal 4 DNA-binding
domain fusion construct.
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FIG. 8. Immunogold localization of BV/ODV-E26 in pVL1392-da26-infected cells. (A) 24 h p.i. (B–E, G–H) 48 h p.i. (I) 48 h p.i. Preimmune antisera.
n, nucleus; c, cytoplasm; v, virogenic stroma; f, fibrillar structures; m, microvesicles; small arrows, normal virogenic stroma; large arrows, abnormal
virogenic stroma; open arrows, ODV envelope labeling; arrowheads, labeling of plasma membrane and nuclear envelope.
factors and then targets to, and associates with intranu-
clear membranes.
The bidirectional transport of -E26 (BV, cell surface, vs
ODV, nuclear) and regulation thereof implies that addi-
tional factor(s), either cellular or viral, are involved in the
regulation of the transport process. Thus, interactions of
viral structural proteins with other protein(s) may play a
crucial role in the regulation of progeny virus assembly
and maturation (BV vs ODV). To identify proteins partic-
ipating in transport or regulation of transport of -E26,
immunoprecipitation and yeast two-hybrid experiments
were performed. These experiments show that -E26 and
FP25K are capable of forming a protein complex and that
the cellular protein actin may also be a component of this
complex (Fig. 7).
Sequence comparisons reveal that -E26 and FP25K
have regions of homology to actin-binding proteins or
cytoskeletal components: -E26 has regions of homology
with tropomyosin (Fig. 6A) and many regions of homol-
ogy to myosin (data not shown); FP25K shares sequence
homology with myosin (Fig. 6B) and cytoplasmic dyneins
(data not shown) and contains a potential actin-binding
helix (Fig. 6C). The sequence similarities, presence of
-E26 and FP25K as structural proteins of the virus
(FP25K, unpublished observations), and the presence of
actin in the immunoprecipitated sample suggest that
-E26/FP25K and actin could be members of a protein
complex that functions to direct nucleocapsid movement
along the cellular cytoskeleton. Several examples of pro-
tein-protein interactions with f-actin are considered in
Fig. 9, however this model does not preclude interactions
with g-actin or other cytoskeletal components. This
model is consistent with previous work which shows that
AcMNPV infection results in the reorganization of cellular
cytoskeleton (Charlton and Volkman, 1991, 1993; Lanier
et al., 1996; Knebel-Morsdorf, personal communication).
The model of baculovirus nucleocapsid/actin interaction
is also consistent with similar interactions demonstrated
for tobacco mosaic virus, Epstein–Barr virus, and Vac-
cinia virus (Mclean et al., 1995; Melamed et al., 1994;
Hiller et al., 1981).
It is not known if BV/ODV-E26 is trafficked into the
nucleus in association with membranes or as a soluble
protein. If -E26 utilizes the more defined pathway of
transport through the nuclear pores, there must be a
molecular process for -E26 to specifically associate with
nuclear membranes after nuclear localization. The use of
-E26 as a marker protein could assist in the identification
of factors responsible for the regulation of -E26 interac-
tion with membranes within the nucleus. If, however,
-E26 traffics to membranes within the nucleus in asso-
ciation with other membranes, as has been proposed for
ODV-E66 (Hong et al., 1997) and lamin B receptor (Smith
and Blobel, 1993; Ye and Worman, 1994), then knowledge
of the molecular mechanism of -E26 transport may pro-
vide insight on the factors necessary for regulation of
this pathway. Considering that viruses are highly efficient
at manipulating, exploiting, and/or redirecting normal
cellular pathways, then insights provided by studies of
AcMNPV of the regulation and pathway of trafficking of
membrane proteins into the nucleus, may reveal path-
ways that might be extended to other species and cell
types.
ACKNOWLEDGMENTS
We thank Janet Parry for the generation of pVL1393-da26 recombi-
nant virus, Danielle Jacks for the production of antibodies to BV/ODV-
E26, and Rebecca Parr, Michael Belayavski, and Haiyan Ma for critical
review and discussion of this manuscript. The authors especially thank
Jared Burks and Gabriela Marcano for development of the yeast two-
hybrid system in this laboratory and Jared for the BV/ODV-E26/FP25K
yeast two-hybrid cross. This study was supported in part by National
Institutes of Health Grant 2RO1GM47552 (M.D.S. and S.C.B.) and the
Texas Agricultural Experiment Station Project TEXO8078 (M.D.S.).
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990).
Basic local alignment search tool. J. Mol. Biol. 215, 403–410.
Ayres, M. D., Howard, S. C., Kuzio, J., Lopez-Ferber, M., and Possee,
R. D. (1994). The complete DNA sequence of Autographa californica
nuclear polyhedrosis virus. Virology 202, 586–605.
Bozzola, J. J., and Russell, L. D. (1992). ‘‘Electron Microscopy,’’ pp.
112–116. Jones & Bartlett, Boston.
Bradford, M. M. (1976). A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the principle of
protein-dye binding. Anal. Biochem. 72, 248–254.
Braunagel, S. C., and Summers, M. D. (1994). Autographa californica
nuclear polyhedrosis virus, PDV, and ECV viral envelopes and nu-
cleocapsids: Structural proteins, antigens, lipid and fatty acid pro-
files. Virology 202, 315–328.
Charlton, C. A., and Volkman, L. E. (1991). Sequential rearrangement
and nuclear polymerization of actin in baculovirus-infected Spodopt-
era frugiperda cells. J. Virol. 65, 1219–1227.
Charlton, C. A., and Volkman, L. E. (1993). Penetration of Autographa
californica nuclear polyhedrosis virus nucleocapsids into IPLB Sf21
cells induces actin cable formation. Virology 197, 245–254.
Dingwall, C., and Laskey, R. A. (1991). Nuclear targeting sequences—A
consensus? TIBS 16, 478–481.
Elliott, G., and O’Hare, P. (1997). Intercellular trafficking and protein
delivery by a herpesvirus structural protein. Cell 88, 223–233.
Guarino, L. A., and Summers, M. D. (1988). Functional mapping of
Autographa californica nuclear polyhedrosis virus genes required for
late gene expression. J. Virol. 62, 463–471.
Hiller, G., Jungwirth, C., and Weber, Klaus (1981). Fluorescence micro-
FIG. 9. Model of interaction of BV/ODV-E26 with FP25K and actin.
Possible methods that BV/ODV-E26, FP25K, and actin might interact to
bind in a complex and allow movement of the virus along actin fila-
ments.
74 BENIYA, BRAUNAGEL, AND SUMMERS
scopical analysis of the life cycle of vaccinia virus in chick embryo
fibroblasts. Exp. Cell Res. 132, 81–87.
Hong, T., Braunagel, S. C., and Summers, M. D. (1994). Transcription,
translation and cellular localization of PDV-E66: A structural protein
of the PDV envelope of Autographa californica nuclear polyhedrosis
virus. Virology 204, 210–222.
Hong, T., Summers, M. D., and Braunagel, S. C. (1997). N-terminal
sequences from Autographa californica nuclear polyhedrosis virus
envelope proteins ODV-E66 and ODV-E25 are sufficient to direct
reporter proteins to the nuclear envelope, intranuclear microvesicles
and the envelope of occlusion derived virus. Proc. Natl. Acad. Sci.
USA 94, 4050–4055.
Laemmli, U. K. (1970). Cleavage of structural proteins during the as-
sembly of the head of bacteriophage T4. Nature 227, 680–695.
Lanier, L. M., Slack, J. M., and Volkman, L. E. (1996). Actin binding and
proteolysis by the baculovirus AcMNPV: The role of virion-associated
V-CATH. Virology 216, 380–388.
McLaughlin, P. J., Gooch, J. T., Mannherz, G.-G., and Weeds, A. G. (1993).
Structure of gelsolin segment 1-actin complex and the mechanism of
filament severing. Nature 364, 685–692.
McLean, B. G., Zupan, J., and Zambryski, P. C. (1995). Tobacco mosaic
virus movement protein associates with the cytoskeleton in tobacco
cells. Plant Cell 7, 2101–2114.
Melamed, I., Stein, L., and Roifman, C. M. (1994). Epstein–Barr virus
induces actin polymerization in human B cells. J. Immunol. 153,
1998–2003.
O’Reilly, D. R., Passarelli, A. L., Goldman, I. F., and Miller, L. K. (1990).
Characterization of the DA26 gene in a hypervariable region of the
Autographa californica nuclear polyhedrosis virus genome. J. Gen.
Virol. 71, 1029–1037.
Smith, S., and Blobel, G. (1993). The first membrane spanning region of
the lamin B receptor is sufficient for sorting to the inner nuclear
membrane. J. Cell Biol. 120, 631–637.
Smith, G. E., and Summers, M. D. (1978). Analysis of baculovirus
genomes with restriction endonucleases. Virology 89, 517–527.
Smith, G. E., and Summers, M. D. (1981). Application of a novel radio-
immunoassay to identify baculovirus structural proteins that share
interspecies antigenic determinants. J. Virol. 39, 125–137.
Summers, M. D., and Smith, G. E. (1987). A manual of methods for
baculovirus vectors and insect cell culture procedures. Texas Agric.
Exp. Stn. Bull. [No. 1555]
Venable, J. H., and Coggeshall, R. (1965). A simplified lead citrate stain
for use in electron microscopy. J. Cell Biol. 25, 407–408.
Volkman, L. E., and Goldsmith, P. A. (1985). Mechanism of neutralization
of budded Autographa californica nuclear polyhedrosis virus by a
monoclonal antibody: Inhibition of entry by absorptive endocytosis.
Virology 143, 185–195.
Wang, Z., and Haunerland, N. H. (1994). Storage protein uptake in
Helicoverpa zea: Arylphorin and VHDL share a single receptor. Arch.
Insect Biochem. Physiol. 26, 15–26.
Webb, N. R., and Summers, M. D. (1990). Expression of proteins using
recombinant baculoviruses. Technique 2, 173–188.
Whitford, M., Stewart, S., Kuzio, J., and Faulkner, P. (1989). Identification
and sequence analysis of a gene encoding gp67, an abundant
envelope glycoprotein of the baculovirus Autographa californica nu-
clear polyhedrosis virus. J. Virol. 63, 1393–1399.
Ye, Q., and Worman, H. J. (1994). Primary structure analysis and lamin
B and DNA binding of human LBR, an integral protein of the nuclear
envelope inner membrane. J. Biol. Chem. 269, 11306–11311.
75AcMNPV ENVELOPE PROTEIN, BV/ODV-E26
